Antitumor agents from Streptomyces anandii: gilvocarcins V, M and E. (Q34284998)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7344705%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

title

Antitumor agents from Streptomyces anandii: gilvocarcins V, M and E (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7344705%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference

Streptomyces lividans

1 reference

inferred from

reverse claim

Streptomyces griseoflavus

1 reference

inferred from

reverse claim

4-[(2R,3R,4R,5S)-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-8-ethyl-1-hydroxy-10,12-dimethoxynaphtho[1,2-c]isochromen-6-one

1 reference

1 reference

4-[(2R,3R,4S,5S)-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-8-ethenyl-1-hydroxy-10,12-dimethoxynaphtho[1,2-c]isochromen-6-one

1 reference

1 reference

1-hydroxy-10,12-dimethoxy-8-methyl-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]naphtho[1,2-c]isochromen-6-one

1 reference

inferred from

reverse claim

4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-8-ethyl-1-hydroxy-10,12-dimethoxynaphtho[1,2-c]isochromen-6-one

1 reference

1 reference

4-[(2R,3R,4S,5S)-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-1-hydroxy-10,12-dimethoxy-8-methylnaphtho[1,2-c]isochromen-6-one

1 reference

D M Balitz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7344705%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

F A O'Herron

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7344705%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

J Bush

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7344705%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

D M Vyas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7344705%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

D E Nettleton

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7344705%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

R E Grulich

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7344705%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

W T Bradner

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7344705%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

T W Doyle

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7344705%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

E Arnold

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7344705%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

J Clardy

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7344705%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

publication date

1981

1 reference

Crossref

full work available at URL

16 September 2022

https://www.jstage.jst.go.jp/article/antibiotics1968/34/12/34_12_1544/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.34.1544?email=unpaywall_01@example.com

published in

The Journal of Antibiotics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7344705%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7344705%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7344705%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

page(s)

1544-1555

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7344705%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.34.1544?email=unpaywall_01@example.com

access restriction status

open access

1 reference

based on heuristic

inferred from online access status

cites work

Gilvocarcins, new antitumor antibiotics. 1. Taxonomy, fermentation, isolation and biological activities

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.34.1544

Fermentation, Isolation, and Antitumor Activity of Sterigmatocystins

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.34.1544

Gilvocarcins, new antitumor antibiotics. 2. Structural elucidation

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.34.1544

Identifiers

DOI

10.7164/ANTIBIOTICS.34.1544

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7344705%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference